fda-approved semaglutide online shortage ends as FDA sets deadline for compounders FDA Approves Oral Semaglutide: First

Findings GLP-1 RAs exhibit potential beneficial effects on depressive symptoms, cognitive function, and reduced risk of suicidal ideation in animal and human models through antioxidative, anti-inflammatory mechanisms, and modulation of neurotransmitter pathways

Lichtenstein P, et al

We offer a comprehensive platform that includes clinical oversight, lab work, and 24/7 access to specialists

Publicly funded research agencies like the National Institutes of Health could play an important role by rapidly investigating the most promising uses of GLP-1 drugs, particularly in areas where pharmaceutical companies may be reluctant to invest, such as traumatic brain injury, for which trials are difficult to run